Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-09-12 1:58 pm Purchase |
2022-09-02 | 13G | Allakos Inc. ALLK |
Frazier Life Sciences Public Fund, L.P. | 2,900,000 5.300% |
2,900,000 (New Position) |
Filing History |
| 2022-09-08 1:19 pm Purchase |
2022-09-06 | 13D | HilleVax, Inc. HLVX |
Frazier Life Sciences Public Fund, L.P. | 9,637,232 28.800% |
513,660 (+5.63%) |
Filing History |
| 2022-08-12 12:35 pm Sale |
2022-08-02 | 13G | Viridian Therapeutics, Inc. VRDN |
Frazier Life Sciences Public Fund, L.P. | 300,000 1.100% |
-1,205,200 (-80.07%) |
Filing History |
| 2022-05-16 12:57 pm Purchase |
2022-03-16 | 13G | TRICIDA INC TCDAQ |
Frazier Life Sciences Public Fund, L.P. | 3,582,093 6.300% |
3,582,093 (New Position) |
Filing History |
| 2022-05-06 4:15 pm Purchase |
2022-04-28 | 13D | HilleVax, Inc. HLVX |
Frazier Life Sciences Public Fund, L.P. | 9,123,572 27.300% |
9,123,572 (New Position) |
Filing History |
| 2022-04-29 12:19 pm Purchase |
2022-04-21 | 13G | Chinook Therapeutics, Inc. KDNY |
Frazier Life Sciences Public Fund, L.P. | 2,770,026 5.000% |
2,770,026 (New Position) |
Filing History |
| 2022-04-18 1:32 pm Purchase |
2022-04-11 | 13G | Trevi Therapeutics, Inc. TRVI |
Frazier Life Sciences Public Fund, L.P. | 3,816,459 10.000% |
3,816,459 (New Position) |
Filing History |
| 2022-03-29 4:23 pm Purchase |
2022-03-24 | 13G | Sierra Oncology, Inc. SRRA |
Frazier Life Sciences Public Fund, L.P. | 2,366,853 10.000% |
1,562,186 (+194.14%) |
Filing History |
| 2022-03-17 12:42 pm Purchase |
2022-03-10 | 13G | Gracell Biotechnologies Inc. GRCL |
Frazier Life Sciences Public Fund, L.P. | 17,104,865 5.100% |
17,104,865 (New Position) |
Filing History |
| 2022-03-01 2:40 pm Purchase |
2022-02-24 | 13G | Cogent Biosciences, Inc. COGT |
Frazier Life Sciences Public Fund, L.P. | 2,188,004 11.000% |
2,188,004 (New Position) |
Filing History |
| 2022-01-31 5:00 pm Purchase |
2022-01-26 | 13D | KalVista Pharmaceuticals, Inc. KALV |
Frazier Life Sciences Public Fund, L.P. | 1,572,192 6.400% |
303,463 (+23.92%) |
Filing History |
| 2022-01-28 1:41 pm Purchase |
2021-12-31 | 13G | Pardes Biosciences, Inc. PRDS |
Frazier Life Sciences Public Fund, L.P. | 2,457,507 3.900% |
2,457,507 (New Position) |
Filing History |
| 2022-01-28 1:39 pm Purchase |
2021-12-31 | 13G | Viridian Therapeutics, Inc. VRDN |
Frazier Life Sciences Public Fund, L.P. | 1,505,200 6.900% |
200,000 (+15.32%) |
Filing History |
| 2021-12-30 4:33 pm Purchase |
2021-12-21 | 13D | KalVista Pharmaceuticals, Inc. KALV |
Frazier Life Sciences Public Fund, L.P. | 1,268,729 5.200% |
1,268,729 (New Position) |
Filing History |
| 2021-12-23 5:28 pm Purchase |
2021-12-20 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
Frazier Life Sciences Public Fund, L.P. | 2,772,062 5.600% |
2,772,062 (New Position) |
Filing History |
| 2021-12-17 2:37 pm Purchase |
2021-12-13 | 13G | Autolus Therapeutics plc AUTL |
Frazier Life Sciences Public Fund, L.P. | 3,730,657 5.100% |
3,730,657 (New Position) |
Filing History |
| 2021-12-17 2:36 pm Purchase |
2021-12-07 | 13G | FS Development Corp. II FSII |
Frazier Life Sciences Public Fund, L.P. | 1,113,700 5.400% |
1,113,700 (New Position) |
Filing History |
| 2021-09-21 3:36 pm Purchase |
2021-09-17 | 13G | GRITSTONE BIO INC GRTSQ |
Frazier Life Sciences Public Fund, L.P. | 4,728,551 8.700% |
4,728,551 (New Position) |
Filing History |
| 2021-08-26 12:56 pm Purchase |
2021-08-16 | 13G | Viridian Therapeutics, Inc. VRDN |
Frazier Life Sciences Public Fund, L.P. | 1,305,200 13.600% |
1,305,200 (New Position) |
Filing History |
| 2021-08-16 4:17 pm Purchase |
2021-08-06 | 13G | Sierra Oncology, Inc. SRRA |
Frazier Life Sciences Public Fund, L.P. | 804,667 9.500% |
804,667 (New Position) |
Filing History |